Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Kielsgaard Kristensen T"'
Autor:
Ustun C; Division of Hematology, Oncology and Cellular Therapy, Rush University, Chicago, IL, USA.; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, USA., Morgan EA; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Ritz EM; Rush Bioinformatics and Biostatistics Core, Rush University, Chicago, IL, USA., Vestergaard H; Department of Hematology, Odense University Hospital, Odense, Denmark., Pullarkat S; Department of Pathology, University of California, Los Angeles, CA, USA., Kluin PM; Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Ohgami R; Department of Pathology, Stanford University, Stanford, CA, USA., Baughn LB; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Kim Y; Department of Pathology, City of Hope National Medical Center, Duarte, CA, USA., Ku NK; Department of Pathology, University of California, Los Angeles, CA, USA., Czuchlewski D; Department of Pathology, University of New Mexico, Albuquerque, NM, USA., Boe Møller M; Department of Hematology, Odense University Hospital, Odense, Denmark.; Department of Pathology, Odense University Hospital, Odense, Denmark.; Mastocytosis Center Odense University Hospital, Odense, Denmark., Schiefer AI; Department of Pathology, Medical University of Vienna, Vienna, Austria., Mrózek K; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Horny HP; Institute of Pathology, Ludwig-Maximilians-University, Munich, Germany., George TI; Department of Pathology, University of New Mexico, Albuquerque, NM, USA.; Department of Pathology, University of Utah, Salt Lake City, UT, USA., Kielsgaard Kristensen T; Department of Pathology, Odense University Hospital, Odense, Denmark.; Mastocytosis Center, Odense University Hospital, Odense, Denmark., Beck T; Rush Bioinformatics and Biostatistics Core, Rush University, Chicago, IL, USA., Nathan S; Division of Hematology, Oncology and Cellular Therapy, Rush University, Chicago, IL, USA., Arana Yi C; Department of Pathology, University of New Mexico, Albuquerque, NM, USA., Yeung C; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; University of Washington School of Medicine, Seattle, WA, USA., Pullarkat V; Division of Hematology and HCT, City of Hope, Duarte, CA, USA., Gotlib J; Stanford Cancer Institute, School of Medicine, Stanford University, Stanford, CA, USA., Akin C; Division of Allergy and Clinical Immunology, University of Michigan, Ann Arbor, MI, USA., Kohlschmidt J; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.; Alliance Statistics and Data Center, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Salhotra A; Department of Pathology, City of Hope National Medical Center, Duarte, CA, USA., Soma L; University of Washington School of Medicine, Seattle, WA, USA., Chen D; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Han SY; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, USA., Cho C; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Sperr W; Department of Internal Medicine I, Division of Hematology & Hemostaseology and Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria., Broesby-Olsen S; Mastocytosis Center Odense University Hospital, Odense, Denmark.; Department of Dermatology and Allergy Centre, Odense Research Center for Anaphylaxis, Odense, Denmark., Linden MA; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA., Dolan M; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA., Hoermann G; Division of Medical and Chemical Laboratory Diagnostics - Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Hornick JL; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Bloomfield C; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Nakamura R; Division of Hematology and HCT, City of Hope, Duarte, CA, USA., Joachim Deeg H; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; University of Washington School of Medicine, Seattle, WA, USA., Litzow MR; Department of Internal Medicine and Division of Hematology, Mayo Clinic, Rochester, MN, USA., Borthakur G; Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Weisdorf D; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, USA., Huls G; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Perales MA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Valent P; Department of Internal Medicine I, Division of Hematology & Hemostaseology and Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria., Marcucci G; Division of Hematology and HCT, City of Hope, Duarte, CA, USA.
Publikováno v:
International journal of laboratory hematology [Int J Lab Hematol] 2021 Feb; Vol. 43 (1), pp. e19-e25. Date of Electronic Publication: 2020 Sep 14.
Autor:
LANGE, Magdalena1, GLEN, Jolanta1, ZABLOTNA, Monika1, NEDOSZYTKO, Boguslaw1, SOKOŁOWSKA-WOJDYŁO, Malgorzata1 mwojd@gumed.edu.pl, REBAŁA, Krzysztof2, ŁUGOWSKA-UMER, Hanna1, NIEDOSZYTKO, Marek3, GÓRSKA, Aleksandra3, SIKORSKA, Monika1, ZAWADZKA, Agata4, NOWICK, Roman1
Publikováno v:
Acta Dermato-Venereologica. Jan2017, Vol. 97 Issue 1, p47-53. 7p.
Autor:
Oriane Cédile, Marcus Hansen, Lene Hyldahl Ebbesen, Hans Herluf Nørgaard Bentzen, Mads Thomassen, Kruse, Torben A., Stephanie Kavan, Michael Boe Møller, Thomas Kielsgaard Kristensen, Jacob Haaber Christensen, Niels Abildgaard, Charlotte Guldborg Nyvold
Publikováno v:
Cédile, O, Hansen, M C, Ebbesen, L H, Nørgaard Bentzen, H H, Thomassen, M, Kruse, T A, Kavan, S, Møller, M B, Kielsgaard Kristensen, T, Christensen, J H, Abildgaard, N & Nyvold, C G 2018, ' NEW POTENTIAL CANDIDATE GENES IN MANTLE CELL LYMPHOMA ', European Hematology Association 23rd congress EHA 2018, Stockholm, Sweden, 14/06/2018-17/06/2018 .
University of Southern Denmark
Cédile, O, Hansen, M C, Ebbesen, L H, Nørgaard Bentzen, H H, Thomassen, M, Kruse, T A, Kavan, S, Møller, M B, Kielsgaard Kristensen, T, Christensen, J H, Abildgaard, N & Nyvold, C G 2018, ' NEW POTENTIAL CANDIDATE GENES IN MANTLE CELL LYMPHOMA ', EHA Learning Center, vol. 2018, PB2322 . < https://learningcenter.ehaweb.org/eha/2018/stockholm/216600/oriane.cdile.new.potential.candidate.genes.in.mantle.cell.lymphoma.html?f=menu=14*media=3*speaker=619671 >
University of Southern Denmark
Cédile, O, Hansen, M C, Ebbesen, L H, Nørgaard Bentzen, H H, Thomassen, M, Kruse, T A, Kavan, S, Møller, M B, Kielsgaard Kristensen, T, Christensen, J H, Abildgaard, N & Nyvold, C G 2018, ' NEW POTENTIAL CANDIDATE GENES IN MANTLE CELL LYMPHOMA ', EHA Learning Center, vol. 2018, PB2322 . < https://learningcenter.ehaweb.org/eha/2018/stockholm/216600/oriane.cdile.new.potential.candidate.genes.in.mantle.cell.lymphoma.html?f=menu=14*media=3*speaker=619671 >
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::141a83f7201074a7d8105144654d77bf
https://portal.findresearcher.sdu.dk/da/publications/63e19213-86f2-4c1d-8f8f-06ece5aeb380
https://portal.findresearcher.sdu.dk/da/publications/63e19213-86f2-4c1d-8f8f-06ece5aeb380
Autor:
Hans Carl Hasselbalch, Mikael Frederiksen, Trine Alma Knudsen, Thomas Kielsgaard Kristensen, Lukas Frans Ocias, Ann Mullally, Bruce M. Wollison, Christina Ellervik, Ole Weis Bjerrum, Donna Neuberg, Torben A Kruse, Torben Mourits-Andersen, Karin de Stricker, Thomas Stauffer Larsen, Anwesha Nag, Aaron R. Thorner, Mads Thomassen, Mette Brabrand, Vibe Skov, Joern Starklint, Lillian Werner, Peter Møller, Daniel El Fassi, Jesper Stentoft, Christopher J. Gibson, R. Coleman Lindsley, William Duke, Ulrik Malthe Overgaard, Dennis Lund Hansen, Marianne Tang Severinsen, Lasse Kjær
Publikováno v:
Knudsen, T A, Skov, V, Werner, L, Duke, W, Gibson, C J, Nag, A, Thorner, A R, Wollison, B, Lund Hansen, D, Larsen, T S, Ellervik, C, El Fassi, D, de Stricker, K, Ocias, L F, Brabrand, M, Weiss Bjerrum, O, Overgaard, U M, Frederiksen, M, Kielsgaard Kristensen, T, Kruse, T A, Thomassen, M, Mourits-Andersen, H T, Severinsen, M T, Jesper, S, Starklint, J, Møller, P, Neuberg, D S, Kjær, L, Hasselbalch, H C, Coleman Lindsley, R & Mullally, A 2019, ' Genomic Profiling of a Phase III Clinical Trial of Interferon Versus Hydroxyurea in MPN Patients Reveals Mutation-Specific and Treatment-Specific Patterns of Response ', Blood, vol. 134, no. Supplement 1, 4202 . https://doi.org/10.1182/blood-2019-126164
Knudsen, T A, Skov, V, Werner, L, Duke, W, Gibson, C J, Nag, A, Thorner, A R, Wollison, B, Lund Hansen, D, Larsen, T S, Ellervik, C, El Fassi, D, de Stricker, K, Ocias, L F, Brabrand, M, Weiss Bjerrum, O, Overgaard, U M, Frederiksen, M, Kielsgaard Kristensen, T, Kruse, T A, Thomassen, M, Mourits-Andersen, T, Severinsen, M T, Jesper, S, Starklint, J, Møller, P, Neuberg, D S, Kjær, L, Hasselbalch, H C, Coleman Lindsley, R & Mullally, A 2019, ' Genomic Profiling of a Phase III Clinical Trial of Interferon Versus Hydroxyurea in MPN Patients Reveals Mutation-Specific and Treatment-Specific Patterns of Response ', American Society of Hematology: 61st Annual Meeting (ASH), Orlando, United States, 07/12/2019-10/12/2019 . < https://ashpublications.org/blood/article/134/Supplement_1/4202/425637/Genomic-Profiling-of-a-Phase-III-Clinical-Trial-of >
Knudsen, T A, Skov, V, Werner, L, Duke, W, Gibson, C J, Nag, A, Thorner, A R, Wollison, B, Lund Hansen, D, Larsen, T S, Ellervik, C, El Fassi, D, de Stricker, K, Ocias, L F, Brabrand, M, Weiss Bjerrum, O, Overgaard, U M, Frederiksen, M, Kielsgaard Kristensen, T, Kruse, T A, Thomassen, M, Mourits-Andersen, T, Severinsen, M T, Jesper, S, Starklint, J, Møller, P, Neuberg, D S, Kjær, L, Hasselbalch, H C, Coleman Lindsley, R & Mullally, A 2019, ' Genomic Profiling of a Phase III Clinical Trial of Interferon Versus Hydroxyurea in MPN Patients Reveals Mutation-Specific and Treatment-Specific Patterns of Response ', American Society of Hematology: 61st Annual Meeting (ASH), Orlando, United States, 07/12/2019-10/12/2019 . < https://ashpublications.org/blood/article/134/Supplement_1/4202/425637/Genomic-Profiling-of-a-Phase-III-Clinical-Trial-of >
Background: To investigate the role of genomics in determining response and resistance to front line treatment in MPN, we performed somatic mutational profiling of the DALIAH trial, a randomized controlled phase III trial of interferon versus hydroxy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::086d55fe777b2ddaceac2b76923d6e4d
https://doi.org/10.1182/blood-2019-126164
https://doi.org/10.1182/blood-2019-126164
Autor:
Hans Carl Hasselbalch, Karin de Stricker, Lukas Frans Ocias, Thomas Kielsgaard Kristensen, Ulrik Malthe Overgaard, Dennis Lund Hansen, Daniel El Fassi, Marianne Tang Severinsen, Jørn Starklint, Thomas Stauffer Larsen, Ole Weis Bjerrum, Klaus Bendtzen, Peter Møller, Jesper Stentoft, Mikael Frederiksen, Torben Mourits-Andersen
Publikováno v:
Ocias, L F, Lund Hansen, D, de Stricker, K, Kielsgaard Kristensen, T, El Fassi, D, Stentoft, J, Starklint, J, Frederiksen, M, Severinsen, M T, Bjerrum, O W, Møller, P, Mourits-Andersen, T, Overgaard, U M, Hasselbalch, H C, Bendtzen, K & Larsen, T S 2015, ' No Development of Neutralizing Antibodies Against Recombinant Interferon-Alpha in Ph-Negative Myeloproliferative Neoplasms : a Prospective Study ', Blood, vol. 126, no. 23, pp. 5177 . < http://www.bloodjournal.org/content/126/23/5177 >
Ocias, L F, Hansen, D L, Kristensen, T K, de Stricker, K, El Fassi, D, Stentoft, J, Starklint, J, Frederiksen, M, Severinsen, M T, Bjerrum, O W, Møller, P, Mouritz-Andersen, T, Overgaard, U M, Hasselbalch, H C, Bendtzen, K & Larsen, T S 2015, ' No Development of Neutralizing Antibodies Against Recombinant Interferon-Alpha in Ph-Negative Myeloproliferative Neoplasms : A prospective Study ', Blood, vol. 126, no. 23, pp. 5177 . < http://www.bloodjournal.org/content/126/23/5177 >
Ocias, L F, Lund Hansen, D, de Stricker, K, Kielsgaard Kristensen, T, El Fassi, D, Stentoft, J, Starklint, J, Frederiksen, M, Severinsen, M T, Bjerrum, O W, Møller, P, Mourits-Andersen, T, Overgaard, U M, Hasselbalch, H C, Bendtzen, K & Larsen, T S 2015, ' No Development of Neutralizing Antibodies Against Recombinant Interferon-Alpha in Ph-Negative Myeloproliferative Neoplasms-a Prospective Study ', 57th American Society of Hematology Annual Meeting and Exposition, Orlando, United States, 04/12/2015-08/12/2015 . < http://www.bloodjournal.org/content/126/23/5177 >
Ocias, L F, Lund Hansen, D, Kielsgaard Kristensen, T, De Stricker, K, El Fassi, D, Stentoft, J, Starklint, J, Frederiksen, M, Severinsen, M T, Bjerrum, O W, Møller, P, Mourits-Andersen, T, Overgaard, U M, Hasselbalch, H C, Bendtzen, K & Larsen, T S 2015, ' No development of neutralizing antibodies against recombinant interferon-alpha in Ph-negative myeloproliferative neoplasms-a prospective study ', Blood, vol. 126, no. 23, 5177 . < http://www.bloodjournal.org/content/126/23/5177 >
Ocias, L F, Hansen, D L, Kristensen, T K, de Stricker, K, El Fassi, D, Stentoft, J, Starklint, J, Frederiksen, M, Severinsen, M T, Bjerrum, O W, Møller, P, Mouritz-Andersen, T, Overgaard, U M, Hasselbalch, H C, Bendtzen, K & Larsen, T S 2015, ' No Development of Neutralizing Antibodies Against Recombinant Interferon-Alpha in Ph-Negative Myeloproliferative Neoplasms : A prospective Study ', Blood, vol. 126, no. 23, pp. 5177 . < http://www.bloodjournal.org/content/126/23/5177 >
Ocias, L F, Lund Hansen, D, de Stricker, K, Kielsgaard Kristensen, T, El Fassi, D, Stentoft, J, Starklint, J, Frederiksen, M, Severinsen, M T, Bjerrum, O W, Møller, P, Mourits-Andersen, T, Overgaard, U M, Hasselbalch, H C, Bendtzen, K & Larsen, T S 2015, ' No Development of Neutralizing Antibodies Against Recombinant Interferon-Alpha in Ph-Negative Myeloproliferative Neoplasms-a Prospective Study ', 57th American Society of Hematology Annual Meeting and Exposition, Orlando, United States, 04/12/2015-08/12/2015 . < http://www.bloodjournal.org/content/126/23/5177 >
Ocias, L F, Lund Hansen, D, Kielsgaard Kristensen, T, De Stricker, K, El Fassi, D, Stentoft, J, Starklint, J, Frederiksen, M, Severinsen, M T, Bjerrum, O W, Møller, P, Mourits-Andersen, T, Overgaard, U M, Hasselbalch, H C, Bendtzen, K & Larsen, T S 2015, ' No development of neutralizing antibodies against recombinant interferon-alpha in Ph-negative myeloproliferative neoplasms-a prospective study ', Blood, vol. 126, no. 23, 5177 . < http://www.bloodjournal.org/content/126/23/5177 >
Background Treatment of Philadelphia chromosome negative chronic myeloproliferative neoplasms (MPNs) with recombinant pegylated interferon alpha2a/b (rIFN-alpha) has proven effective. It is well known that prolonged therapy with recombinant type 1 in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94f46614e756f8a08ffa4618c008ee66
http://www.bloodjournal.org/content/126/23/5177
http://www.bloodjournal.org/content/126/23/5177
Autor:
Thomas Kielsgaard Kristensen, Sigurd Broesby-Olsen, Hanne Vestergaard, Carsten Bindslev-Jensen, Michael Boe Møller
Publikováno v:
Kielsgaard Kristensen, T, Broesby-Olsen, S, Vestergaard, H, Bindslev-Jensen, C & Møller, M B 2013, ' KIT D816V mutation-positive cell fractions in lesional skin biopsies from adults with systemic mastocytosis ', Dermatology, vol. 226, no. 3, pp. 233-7 . https://doi.org/10.1159/000349986
Kielsgaard Kristensen, T, Broesby-Olsen, S, Vestergaard, H, Bindslev-Jensen, C & Møller, M B 2013, ' KIT D816V Mutation-Positive Cell Fractions in Lesional Skin Biopsies from Adults with Systemic Mastocytosis ', EAACI European Academy of Allergy and Clinical Immunology, Milano, Italy, 22/06/2013-26/06/2013 .
University of Southern Denmark
Kielsgaard Kristensen, T, Broesby-Olsen, S, Vestergaard, H, Bindslev-Jensen, C & Møller, M B 2013, ' KIT D816V Mutation-Positive Cell Fractions in Lesional Skin Biopsies from Adults with Systemic Mastocytosis ', EAACI European Academy of Allergy and Clinical Immunology, Milano, Italy, 22/06/2013-26/06/2013 .
University of Southern Denmark
Most adults with systemic mastocytosis (SM) carry the somatic KIT D816V mutation, but the occurrence of the mutation in lesional skin remains to be characterized.To assess the distribution and fraction of KIT D816V mutation-positive cells in lesional
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::a4a4ee9850ce1ebd62686ab1d52c3914
https://portal.findresearcher.sdu.dk/da/publications/ae36134b-b134-463b-b2f3-f6e2aa73269f
https://portal.findresearcher.sdu.dk/da/publications/ae36134b-b134-463b-b2f3-f6e2aa73269f
Publikováno v:
Allergy; Aug2017 Supplement S103, Vol. 72, p824-867, 44p
Autor:
Maibritt Mardahl, Trine H. Mogensen, Mette Holm, Alon Schneider, Jens Erik Veirum, Mette Christiansen, Thomas Kielsgaard Kristensen, Sofie E. Jørgensen, Klas Raaschou-Jensen, Kristian Assing, Isik Somuncu Johansen
Publikováno v:
Mardahl, M, Jørgensen, S E, Schneider, A, Raaschou-Jensen, K, Holm, M, Veirum, J, Kristensen, T K, Johansen, I S, Christiansen, M, Assing, K & Mogensen, T H 2019, ' Impaired immune responses to herpesviruses and microbial ligands in patients with MonoMAC ', British Journal of Haematology, vol. 186, no. 3, pp. 471-476 . https://doi.org/10.1111/bjh.15947
University of Southern Denmark
Mardahl, M, Jørgensen, S E, Schneider, A, Kræsten Raaschou Jensen, K, Holm, M, Veirum, J E, Kielsgaard Kristensen, T, Johansen, I S, Christiansen, M, Assing, K & Mogensen, T 2019, ' Impaired immune responses to herpesviruses and microbial ligands in patients with MonoMAC ', 2019 Focused Meeting of the European Society for Immunodeficiencies (ESID 2019), Bruxelles, Belgium, 18/09/2019-21/09/2019 .
University of Southern Denmark
Mardahl, M, Jørgensen, S E, Schneider, A, Kræsten Raaschou Jensen, K, Holm, M, Veirum, J E, Kielsgaard Kristensen, T, Johansen, I S, Christiansen, M, Assing, K & Mogensen, T 2019, ' Impaired immune responses to herpesviruses and microbial ligands in patients with MonoMAC ', 2019 Focused Meeting of the European Society for Immunodeficiencies (ESID 2019), Bruxelles, Belgium, 18/09/2019-21/09/2019 .
MonoMAC is a complex primary immunodeficiency caused by mutations in the myeloid transcription factor GATA2, characterized by multilineage cytopenia with malignant complications and severe infections, including mycobacteria and herpesviruses. We desc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7dcdfa9bbe7244286e25ef351c1d7bcc
https://doi.org/10.1111/bjh.15947
https://doi.org/10.1111/bjh.15947
Autor:
Cecilia Yeung, Sunita Nathan, Linda B. Baughn, Hans-Peter Horny, Gautam Borthakur, Ana Iris Schiefer, Gregor Hoermann, Cem Akin, Ethan M. Ritz, David R. Czuchlewski, Vinod Pullarkat, Ryo Nakamura, Thomas Kielsgaard Kristensen, Michelle M Dolan, Peter Valent, Michael A. Linden, Se Y. Han, Gerwin Huls, Tracy I. George, Lori Soma, Wolfgang R. Sperr, Jessica Kohlschmidt, Jason L. Hornick, Michael Boe Møller, Sheeja T. Pullarkat, Sigurd Broesby-Olsen, Elizabeth A. Morgan, Celalettin Ustun, Robert S. Ohgami, Todd Beck, Mark R. Litzow, Miguel-Angel Perales, Nam K. Ku, Philip M. Kluin, Daniel J. Weisdorf, Clara D. Bloomfield, Dong Chen, Amandeep Salhotra, Christina Cho, Guido Marcucci, Krzysztof Mrózek, H. Joachim Deeg, Young L. Kim, Hanne Vestergaard, Cecilia Arana Yi, Jason Gotlib
Publikováno v:
International journal of laboratory hematology, 43(1), E19-E25. Wiley
Int J Lab Hematol
Ustun, C, Morgan, E A, Ritz, E M, Vestergaard, H, Pullarkat, S, Kluin, P M, Ohgami, R, Baughn, L B, Kim, Y, Ku, N K, Czuchlewski, D, Boe Møller, M, Schiefer, A I, Mrózek, K, Horny, H P, George, T I, Kielsgaard Kristensen, T, Beck, T, Nathan, S, Arana Yi, C, Yeung, C, Pullarkat, V, Gotlib, J, Akin, C, Kohlschmidt, J, Salhotra, A, Soma, L, Chen, D, Han, S Y, Cho, C, Sperr, W, Broesby-Olsen, S, Linden, M A, Dolan, M, Hoermann, G, Hornick, J L, Bloomfield, C, Nakamura, R, Joachim Deeg, H, Litzow, M R, Borthakur, G, Weisdorf, D, Huls, G, Perales, M A, Valent, P & Marcucci, G 2021, ' Core-binding factor acute myeloid leukemia with inv(16) : Older age and high white blood cell count are risk factors for treatment failure ', International Journal of Laboratory Hematology, vol. 43, no. 1, pp. e19-e25 . https://doi.org/10.1111/ijlh.13338
Int J Lab Hematol
Ustun, C, Morgan, E A, Ritz, E M, Vestergaard, H, Pullarkat, S, Kluin, P M, Ohgami, R, Baughn, L B, Kim, Y, Ku, N K, Czuchlewski, D, Boe Møller, M, Schiefer, A I, Mrózek, K, Horny, H P, George, T I, Kielsgaard Kristensen, T, Beck, T, Nathan, S, Arana Yi, C, Yeung, C, Pullarkat, V, Gotlib, J, Akin, C, Kohlschmidt, J, Salhotra, A, Soma, L, Chen, D, Han, S Y, Cho, C, Sperr, W, Broesby-Olsen, S, Linden, M A, Dolan, M, Hoermann, G, Hornick, J L, Bloomfield, C, Nakamura, R, Joachim Deeg, H, Litzow, M R, Borthakur, G, Weisdorf, D, Huls, G, Perales, M A, Valent, P & Marcucci, G 2021, ' Core-binding factor acute myeloid leukemia with inv(16) : Older age and high white blood cell count are risk factors for treatment failure ', International Journal of Laboratory Hematology, vol. 43, no. 1, pp. e19-e25 . https://doi.org/10.1111/ijlh.13338
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6cbdad78a1fb16347206351375937cb
https://research.rug.nl/en/publications/5fb16649-2929-4488-9045-113a260640c0
https://research.rug.nl/en/publications/5fb16649-2929-4488-9045-113a260640c0
Publikováno v:
Nielsen, A B, Kielsgaard Kristensen, T, Arsic, I & Festersen Nielsen, M 2021, ' Akut appendicitis efter koloskopi ', Ugeskrift for Laeger, bind 183, nr. 13, V08200600 . < https://ugeskriftet.dk/videnskab/akut-appendicitis-efter-koloskopi >
Severe complications following colonoscopy are rare. This is a case report of a 44-year-old woman, who presented to an emergency department (ED) 24 hours following an uncomplicated colonoscopy performed in an out-patient clinic. Acute contrast-enhanc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3062::e224ef03d468fcb6456a5f04efa0b4ca
https://ugeskriftet.dk/videnskab/akut-appendicitis-efter-koloskopi
https://ugeskriftet.dk/videnskab/akut-appendicitis-efter-koloskopi